OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Tuberculosis and Lung Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
TB infection in adults with diabetes mellitus in Uganda	129
Clinical profile and outcomes of paediatric central nervous system tuberculomas	105
TB-related deaths among adults in Guinea-Bissau	77
Launch of a second wave of IJTLD Clinical Standards for Lung Health	51
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	47
Dr Christopher Zishiri	41
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	41
The impact of sputum quality on Xpert positivity in active case-finding for TB	40
Screening of refugees from Ukraine for TB: a TBnet survey	30
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	28
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	28
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	27
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	26
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	25
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	24
Yield of community outreach events for TB screening	22
Latent TB and depressive symptoms in household contacts of persons with active TB	22
CFU counting may underestimate TB bacilli number of blood, biasing limit of detection estimates in spiking experiments	21
WHO target product profiles for TB preventive treatment	20
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	18
TB in ageing populations: lessons from Japan and Korea	18
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	17
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	17
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	17
The COVID-19 pandemic does not bode well for TB control	17

Are schools prepared to manage students with an asthma attack?	16
Reply to: Observations on malnutrition and anti-TB drugs in Ghana	16
Literature Highlights	15
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	14
Assessment of TB patient cost – what about the mitigation strategy?	14
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	14
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	14
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	14
Standards for clinical trials for treating TB	14
Occupational transmission of TB infection during autopsy	13
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	13
Accessibility and TB patient satisfaction in Nigeria	13
Impact of revised definitions for extensively drug-resistant TB on disease classification	13
A cohort study exploring variables associated with mortality in critically ill TB patients	12
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	12
Prevalence of chronic airflow obstruction in sub-Saharan Africa	12
TB testing in HIV-positive patients prior to antiretroviral treatment	12
Performance of spirometry assessment at TB diagnosis	12
TB disease yield from household contact screening of TB index patients in Pakistan	12
Perceived stigma among people with TB and household contacts	12
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	11
Risk factors for severe COPD exacerbation in Chinese adults	11
Patterns of TB transmission in the United States, 2011–2017	11
Post-TB lung disease: keep going beyond TB!	11
Paediatric TB care in the United Kingdom	10
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	10
A novel method for contact tracing for TB at household and community level	10
Updated guidelines for child and adolescent TB	10
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	10
Facilitators and barriers to adolescent participation in a TB clinical trial	10
Decentralising TB diagnosis and contact management: impact on detection and preventive treatment in children	9
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services	9
EJ-antisynthetase syndrome presenting as severe acute respiratory distress syndrome	9
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	9
Health status of Italian children living close to cultivations sprayed with pesticides	9
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	9
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	9
TB case fatality and recurrence in a private sector cohort in Mumbai, India	9
Population attributable fraction for smoking and diabetes in TB	9
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	8
Meeting of two pandemics in prison: a challenging event in a challenging environment	8
Cascade of care for people with TB and diabetes in India	8
Medical management of large and multiple pulmonary echinococcal cysts	8
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	8
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	8
Perceived stigma related to TB preventive therapy	8
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	7
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	7
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB	7
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	7

If you want to go far, go together: standardisation and data sharing in TB drug development	7
An approach for improving the quality of country-level TB modelling	7
The effect of systematic screening of the general population on TB case notification rates	7
Evaluation of QFT-Plus performance using blood samples stored at room temperature	7
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	7
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	7
TB notifications among citizens and non-citizens in Taiwan	7
Use of computed tomography for the diagnosis of TB during a paediatric outbreak	7
Protecting healthcare workers from TB	7
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	7
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	7
Rifampicin-resistant TB: discordance between Xpert^® MTB/RIF and MTBDRplus results	6
Predictors of TB disease in HIV-exposed children from Southern Africa	6
Bronchiectasis exacerbations: certainties and future challenges	6
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	6
Population attributable fraction for undernutrition due to TB does not take account of bidirectional causality	6
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	6
TB disease in children from the prehistoric era	6
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	6
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	6
Community-based intervention and health education to scale up TB preventive treatment for children	6
Proportions of Xpert MTB/RIF Ultra ‘trace’ results vary widely among different populations with presumptive TB	6
Characteristics, risk factors and outcomes of critically ill patients with active TB	6
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	6
TB and COVID-19 co-infection in a pulmonology hospital	6
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	6
Impact of COVID-19 on hospitalisations for asthma	6
Extemporaneously compounded liquid formulations of clofazimine	6
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	6
Effect of biological therapies on TB treatment outcomes	6
Clinical experience of TB in patients treated with anti-TNF-α	6
Cost of TB prevention and treatment in the Philippines in 2017	6
Contribution of Xpert^® MTB/RIF to pediatric TB diagnosis in Mozambique	6
TB and chronic pulmonary aspergillosis: a few relevant points	6
A new understanding of clinical patterns in post-TB lung disease	6
Estimating TB survival ‐ mind the immortal-time gap	6
Time to integrate epidemiological and economic models for TB	6
Urine LAM diagnostics can close the deadly testing gap for TB	6
The high costs facing TB-affected households in Mali	6
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB	6
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	6
Financial impact of COVID-19 on TB patients in India	6
Real-world implementation of video-observed therapy in an urban TB program in the United States	6
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
Early mortality during rifampicin-resistant TB treatment	5
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	5
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	5
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	5
Implementation of modified, all-oral shorter TB regimens in Armenia	5
Glutathione and N-acetylcysteine in TB management	5
National approaches to TB care in adolescents	5
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	5
After DOT, the brave new world?	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5
Early line-probe assay using DNA specimens in patients with pulmonary TB	5
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	5
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	5
Family directly observed therapy for children with drug-resistant TB	5
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	5
TB mortality in low-incidence countries: can we reduce it further?	5
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	5
TB screening of Ukrainian refugees in Germany	5
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	5
Diabetes characteristics and long-term management needs in diabetic TB patients	5
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	5
Literature Highlights	5
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	5
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	5
Factors associated with presenting to private sector care providers at the onset of TB symptoms	5
A bold new future for the IJTLD	5
WHO drug-resistant TB guidelines 2022: what is new?	5
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	5
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs	5
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	5
Potential use of nasopharyngeal aspirate for pediatric TB diagnosis	4
Evaluation of the MolecuTech^® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	4
TB screening of children from Ukraine in Germany	4
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	4
Programmatic implications of a sub-national TB prevalence survey in India	4

A comprehensive person-centred TB care model, from malnutrition to mental health	4
Bridging the gap: key evidence needed to strengthen global policies to end TB	4
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	4
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	4
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	4
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	4
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	4
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	4
Clinical outcomes in comorbid COVID-19 and TB cases	4
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	4
Launch of the IJTLD Clinical Standards for Lung Health	4
TB screening, prevention and treatment cascade in a Malawi prison	4
Impact of the COVID-19 pandemic on TB infection testing	4
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	4
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	4
Factors associated with referrals for directly observed treatment and unsuccessful treatment	4
The 100^th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	4
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	4
Establishing proof of concept for utility of Trueprep^®-extracted DNA in line-probe assay testing	4
Interventions to enhance treatment adherence and retention in care for HIV-TB	4
The scientific response to TB – the other deadly global health emergency	3
Highlighting the characteristics of TB disease in older people	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	3
Ocular TB in Western Australia	3
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	3
TB in the elderly: clinical features and outcomes	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
Concomitant pulmonary disease is common among patients with extrapulmonary TB	3
Outcomes for people with TB by disease severity at presentation	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
A structured 2-week follow-up visit in the cascade of care for TB increases case detection	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
Reply to: “TB and chronic pulmonary aspergillosis: a few relevant points”	3
The economic burden of TB-affected households in DR Congo	3
Ukraine embraces innovation in its fight against another deadly foe: TB	3
Increasing trend of non-tuberculous mycobacteria in a Croatian hospital, 2012–2019	3
Time to care-seeking for TB symptoms	3
Electronic nicotine delivery system use among current smokers in India	3
Work-related interstitial lung diseases: reassessing the burden	3
Characterising cause of death among people treated for drug-susceptible TB in India	3
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	3
Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment	3
Introduction of new drugs for drug-resistant TB in Iraq	3
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose	3
Post-TB bronchiectasis: clinical characteristics and microbiology	3
Eosinophils in bronchiectasis: searching for a new endotype	3
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
Preventive treatment for MDR-TB exposure in households	3
Better data for country-level TB resource allocation are urgently required	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
Prevalence, temporal trends and risk factors of drug-resistant TB in Zibo, China, 2018–2021	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Adverse events among persons with TB using in-person vs. electronic directly observed therapy	3
Towards meaningful inclusion of people affected by TB: lessons from the COVID-19 response	3
The effect of TB patient delay on loss to follow-up in Portugal	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
Therapeutic drug monitoring for isoniazid and rifampicin exposure	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	3
The interplay between TB and lung cancer: risk, prognosis and treatment dynamics	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	3
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	3
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	3
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB	3
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	3
Contributions of GeneXpert^® to TB diagnosis in Myanmar	3
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	3
Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
A comparison of bronchoalveolar lavage and gastric aspirate for diagnosis of paediatric TB	3
Literature Highlights	2
Clinical and imaging characteristics associated with hospitalisation for post-TB lung disease	2
Clinical standards for the management of adverse effects during treatment for TB	2
Household drug-resistant TB contact tracing in Tajikistan	2
Ultrasound-guided lymph node biopsy in smear-negative children and adolescents with suspected TB	2
Tackling the many layers of stigma is essential for the “End TB Strategy”	2
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?	2
Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB	2
Asthma and allergies in schoolchildren: data from the European SINPHONIE study	2
Travel history and challenges of screening for latent TB infection in child asylum seekers	2
A randomised controlled trial to evaluate a medication monitoring system for TB treatment	2
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	2
Cost of TB services in healthcare facilities in Kenya (No 3)	2
Use of local data to evaluate TB contact investigation in Malawi	2
Response to: The pressing need for standardised diagnostic criteria for obstructive ventilatory impairment in adults and children	2
Further effort is needed to avoid irrational use after drug susceptibility testing for drug-resistant TB	2
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children	2
Screening for active and latent TB among migrants in France	2
Parental TB associated with offspring asthma and rhinitis	2
Low serum levels of anti-TB drugs in a high TB setting	2
The cascade of care for household contacts of people with drug-resistant TB	2
Improving enrolment for TB preventive treatment	2